Guardant Health (GH) PT Raised to $60 at Barclays
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $170.69 +1.67%
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $55.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Netease Inc. (9999:HK) (NTES) PT Lowered to HK$226 at Macquarie
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
